Ciba-Geigy Report issue

Contributed to NME For profit Phase 2
Founded: Basel Switzerland (1971)
Status: Acquired by Novartis (1996)

Organization Overview

First Clinical Trial
None
First Marketed Drug
1977
calcitonin, human (cibacalcin)
First NDA Approval
1977
calcitonin, human (cibacalcin)
Last Known Activity
1990

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Marketed Drugs (7)

antazoline (vasocon-a) (1990 NDA)

benazepril (lotensin) (NDA)

calcitonin, human (cibacalcin) (1977 NDA)

clomipramine (anafranil) (1989 NDA)

diclofenac (voltaren) (NDA)

metoprolol (lopressor) (NDA)

ursodeoxycholic acid (NDA)

Drugs in Phase 2 Trials (1)

Key: Ciba-Geigy (0) Acquired (1)

imipramine (tofranil) (1 trial)

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 1